Resolution Therapeutics Announces Approval of Clinical Trial Application by AEMPS to Expand Phase 1/2 EMERALD Study of RTX001 into Spain ...Middle East

- EMERALD Study will investigate the safety and efficacy of RTX001, an engineered macrophage cell therapy, in patients with end-stage liver disease - Recruitment already underway in the U.K., following recent MHRA approval EDINBURGH, Scotland and LONDON, Nov. 19, 2024 /PRNewswire/ --...

Hence then, the article about resolution therapeutics announces approval of clinical trial application by aemps to expand phase 1 2 emerald study of rtx001 into spain was published today ( Tuesday 19/11/2024 - 11:36 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Resolution Therapeutics Announces Approval of Clinical Trial Application by AEMPS to Expand Phase 1/2 EMERALD Study of RTX001 into Spain )

Also on site :

• Three men accused of kidnapping family in Perinton pleaded not guilty in court Monday
• ‘Survivor’ Host Jeff Probst’s Brother Scott Probst Dead
• Mediator Pakistan allowed Iran to park military aircraft on its airfields